These international patent data are derived from patent families, based on US drug-patent linkages.
Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
|US Patent Number||US Expiration Date||US Applicant||US Tradename||Generic Name|
|7,910,132||Sep 24, 2019|
Sentynl Theraps Inc
|8,512,747||Sep 24, 2019|
|8,454,996||Sep 24, 2019|
Orexo Us Inc
buprenorphine hydrochloride; naloxone hydrochloride
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.